ULIPRISTAL ACETATE EXELTIS 30 mg, film-coated tablet tablet
Active ingredients: Ulipristal acetate
Commercialized according to BDPM
Film-coated tablettabletorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ULIPRISTAL ACETATE EXELTIS 30 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette PVC PVDC aluminium de 1 comprimé
- Marketing authorisation holder
- EXELTIS SANTE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Jun 2020
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62621512CIP73017209CIP133400930172094Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTATE D'ULIPRISTALcomprimé | 30 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.